Press release
Competitive Landscape: Key Leaders and New Entrants in the Pharmaceutical Lipid-Based Excipients Market
Pharmaceutical Lipid-Based Excipients Market
Projected Market Value and Growth Trajectory of the Pharmaceutical Lipid-Based Excipients Market
The pharmaceutical lipid-based excipients market is anticipated to reach a valuation of $2.17 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.2%. This upward trend is driven by rising demand for sophisticated drug delivery systems, broader adoption of mRNA and gene therapies, an expanding portfolio of drugs with poor water solubility, and a heightened focus on personalized medicine. Supportive regulations and increased investment in biopharmaceutical manufacturing infrastructure also contribute to this growth. Key developments expected during the forecast period include innovations in lipid nanoparticle delivery methods, enhanced solubility solutions, sustainable lipid sourcing, scalable manufacturing processes, and the application of lipid-based excipients in both oral and injectable drug formulations.
Download a free sample of the pharmaceutical lipid-based excipients market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp
Primary Companies Leading the Pharmaceutical Lipid-Based Excipients Market
The market is shaped by a range of prominent players including Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, and Biosynth.
In June 2024, CordenPharma, headquartered in Switzerland, formed a partnership with Certest Biotec S.L., a biotechnology firm based in Spain. This collaboration is designed to incorporate Certest's proprietary ionizable lipids into CordenPharma's lipid nanoparticle (LNP) formulation services, thereby enhancing RNA/DNA therapeutic development through combined expertise in lipid innovation, manufacturing, and regulatory affairs.
Emerging Trends Highlighting Growth in the Pharmaceutical Lipid-Based Excipients Market
Industry leaders are investing strategically to foster innovation and improve drug delivery capabilities. A notable example occurred in November 2024 when Gattefossé SAS, a French chemical manufacturer, inaugurated a state-of-the-art Technical Center of Excellence in Mumbai. This facility aims to support the expanding pharmaceutical market in India by providing specialized laboratories and tailored support focused on excipient innovation, including bioavailability improvements, sustained release, and topical formulation advancements. The center is equipped with pharmaceutical and personal care application labs, designed to promote collaboration and innovation while strengthening the company's footprint in the Asia-Pacific region.
View the full pharmaceutical lipid-based excipients market report:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-lipid-based-excipients-global-market-report
Detailed Segmentation Driving the Pharmaceutical Lipid-Based Excipients Market
The pharmaceutical lipid-based excipients market is categorized into several key segments:
1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC (Glyceryl Mono/Diesters of C16/C18), Hard Fats, Medium Chain Triglycerides, Lecithin and Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, and Other Excipient Types.
2) By Product Applications: Oral Formulations, Parenteral, Topical, Ophthalmic, Suppositories, and Other Applications.
3) By Disease Application: Cardiovascular, Neurological, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, and Other Disease Categories.
4) By Age Group: Pediatric (0-18 years), Adult (19-64 years), and Geriatric (65+ years).
5) By End Users: Pharmaceutical Manufacturers, Contract Development and Manufacturing Organizations, and Other Users.
Further Subcategories of Excipient Types
Oils include soybean, olive, palm, sunflower, and other oils. Hydrogenated vegetable oils cover hydrogenated soybean, palm, cottonseed, and other variants. GMCC is broken down into glyceryl monostearate, distearate, monopalmitate, and others. Hard fats consist of hydrogenated castor oil, palm kernel oil, coconut oil, and additional types. Medium Chain Triglycerides (MCTs) include capric, caprylic, caprylic-capric triglycerides, among others. Lecithins and phospholipids encompass soy lecithin, egg lecithin, phosphatidylcholine, phosphatidylserine, and other forms. Sodium oleate is divided into pharmaceutical, food, and industrial grades. Capri-caprylic mono/diglycerides include monoglycerides and diglycerides. Other excipient types cover sucrose esters, fatty acid esters, PEGylated lipids, and miscellaneous lipids.
This detailed segmentation provides a comprehensive framework for understanding the various components driving growth and innovation within the pharmaceutical lipid-based excipients market.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Competitive Landscape: Key Leaders and New Entrants in the Pharmaceutical Lipid-Based Excipients Market here
News-ID: 4318638 • Views: …
More Releases from The Business Research Company
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Pr …
The preeclampsia drugs market is poised for significant expansion over the coming years, driven by advances in medical technology and personalized treatment approaches. As awareness and diagnosis improve, the demand for effective therapies is expected to rise, shaping the future landscape of this crucial healthcare segment. Let's explore the market's size, key players, emerging trends, and detailed segment breakdowns.
Forecasted Growth and Market Size of the Preeclampsia Drugs Market
The…
In-Depth Examination of Segments, Industry Developments, and Key Players in the …
"The nutritional supplements market is on the brink of substantial expansion, driven by evolving consumer preferences and innovations. As awareness about personalized health solutions grows, this sector is set to experience remarkable changes and opportunities in the coming years. Let's explore the expected market size, leading players, emerging trends, and segment details that define the nutritional supplements industry today.
Expected Market Size and Growth Trajectory of the Nutritional Supplements Market …
Key Strategic Developments and Emerging Changes Shaping the Acute Ischemic Strok …
The acute ischemic stroke drugs market is set for significant expansion in the coming years, driven by ongoing innovations and advancements in treatment options. As the healthcare landscape evolves, new therapies and technologies are shaping the future of stroke care, promising improved patient outcomes and broader access to effective medications.
Projected Growth and Market Size of the Acute Ischemic Stroke Drugs Market
The market for acute ischemic stroke drugs is…
Competitive Landscape: Key Market Leaders and Rising Competitors in the Lentivir …
The lentiviral vector market is emerging as a fast-growing sector within the biotechnology and gene therapy industries. Driven by advancements in personalized medicine and gene editing, this market is poised for significant expansion over the coming years. Let's explore the market's size projections, key players, notable trends, and the segmentation that defines this dynamic field.
Projected Market Value and Growth Trajectory for Lentiviral Vectors
The lentiviral vector market is expected…
More Releases for Excipient
Chronic Disease Rise Fuels Albumin Excipient Market Growth: The Driving Engine B …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Albumin Excipient Market Size Growth Forecast: What to Expect by 2025?
The size of the albumin excipient market has been witnessing significant growth in recent years. It is estimated to rise from $4.85 billion in 2024 to $5.15 billion in 2025 with a Compound Annual Growth Rate (CAGR) of…
Biological Excipient Market Key Drivers for 2025
The Biological Excipient market is a crucial segment of the pharmaceutical industry, providing essential support for the efficacy and stability of drug formulations. Biological excipients are naturally derived substances that facilitate the delivery of active pharmaceutical ingredients (APIs), ensuring that medications retain their intended therapeutic effects while enhancing patient compliance and safety. The relevance of this market spans a wide range of applications, including oral and topical formulations, which cater…
Biopharmaceutical Excipient Market Growth Fueled by Rising Biologics Demand.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Excipient Manufacturing Market- by Type of Biologics (Antibodies, Vaccines, Cell Therapies and Other Biologics), Type of Excipient (Carbohydrates, Polymers, Solubilizers/Surfactants, Polyols, Proteins/Amino Acids and Others), Scale of Operation (Preclinical, Clinical and Commercial), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to the latest research by InsightAce Analytic, the global Biopharmaceutical Excipient Manufacturing market…
Biopharmaceutical Excipient Manufacturing: Driving Efficiency in Pharmaceutical …
"Biopharmaceutical Excipient Manufacturing Market" in terms of revenue was estimated to be worth $1,372.7 Mn in 2023 and is poised to reach $2,892.5 Mn by 2031, growing at a CAGR of 9.82% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1197
Market Analysis:
Biopharmaceutical excipients serve an important role in biologic drug formulation by stabilizing, delivering, and improving the performance of active pharmaceutical…
Isotope-Labeled Excipient Market Revenue, Insights, Overview, Outlook, Analysis
Isotope-Labeled Excipient Market
Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario,…
Global Pharmaceutical Excipient Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pharmaceutical Excipient Market is projected to grow from USD 8.6 Billion in 2022 to USD 11.5 billion in 2027 at a CAGR of 5.9% from 2022 to 2027.
The increase in demand for oral solid pharmaceutical drugs, the emergence of novel therapeutics on account of the growing number of pharmaceutical companies, the rapidly growing pharmaceuticals market, and…
